Deep Track Capital, LP 13D and 13G filings for Keros Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:53 am Sale | 2022-12-31 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital, LP | 0 0.000% | -1,300,000 (Position Closed) | Filing |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital, LP | 1,300,000 5.500% | 11,276 (+0.87%) | Filing |
| 2021-12-30 4:37 pm Purchase | 2021-12-29 | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital, LP | 1,288,724 5.450% | 1,288,724 (New Position) | Filing |